Navigation Links
Optimizing Early Stage Drug Development and Best Practices in Clinical Trial Supply Management to be Presented by Catalent Experts at Biopharma Asia in Singapore

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health products and global clinical supply services, today announced that Mr. Paul Cao, General Manager, Clinical Trial Supply, China, and Mr. Julien Meissonnier, Vice President, Science and Technology, will be presenting at the upcoming BioPharma Asia Conference, to be held at the Suntec Singapore International Exhibition & Convention Centre, Singapore, on March 22nd – 24th, 2016.

Mr. Cao’s presentation, on Wednesday March 23rd, at 12:40 p.m., is entitled “Best Practice and Considerations for Running Successful Clinical Trials in and from Asia,” and will discuss current trends and challenges facing companies running clinical trials in this market, and strategies to overcome these. A case study demonstrating successful planning through combining clinical supply management and a patient- and site-centric supply network will be presented, while Mr. Cao will also discuss approaches for Asian innovators looking to manage clinical trials in the US and Europe.

Later that day at 2:00 p.m., Mr. Meissonnier is to present “Accelerating Oral Drug Development Through Systematic Early Technology Selection.” He will discuss how accurate early stage prediction of compounds’ physicochemical and biopharmaceutical properties can be beneficial in the selection of suitable technologies that optimize bioavailability, safety, and stability of any new chemical entity. The presentation will also demonstrate how working with development partners with expertise in preformulation and formulation development can facilitate successful and streamlined design of pharmacokinetic and efficacy/toxicity studies, leading to pharmacologically effective and developable candidates entering the clinic, and ultimately the market, faster.

Prior to joining Catalent, Mr. Cao was most recently the General Manager for Fisher Clinical Service (Beijing, China). An industry veteran, who is experienced with GMP and FDA certification in China, he has an extensive background in secondary packaging and cold chain distribution. Prior to Fisher he worked for Zuellig Pharma and has extensive experience in drug distribution. Mr. Cao has a Bachelor of Science Degree in Industrial Electrical Automation from Beijing University of Science and Technology and also holds an MBA from Vlerick Leuven Ghent Management School, K. U. Leuven, Belgium. Additionally, he has a Bachelor’s degree in Computer Science & Artificial Intelligence from K. U. Leuven, Belgium.

As Vice President, Science and Technology at Catalent, Julien Meissonnier leads the company's scientific, technology, and product development. Previously, he led Catalent's European R.P. Scherer softgel R&D teams, focussed on early stage screening activities, product development, scale-up and technology transfer, directing clinical supplies, and supporting product launches. Mr. Meissonnier has 17 years of experience in pharmaceutical development. He earned his Engineering degree in Physico-Chemistry from the ENSI in Caen, France. He is also a member of the Board of the Catalent Applied Drug Delivery Institute.

For more information on the 2016 BioPharma Asia Conference and Exhibition, visit: and to arrange a meeting with attending Catalent executives at the event, contact Richard Kerns at NEPR- richard(at)nepr(dot)eu.

About Catalent

Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health and global clinical supply services. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,700 people, including over 1,000 scientists, at 31 facilities across 5 continents, and in fiscal 2015 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit

More products. Better treatments. Reliably supplied.™

Read the full story at

Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved

Related medicine news :

1. Research Presented at RSNA Shows Volpara Solutions’ VolparaDensity Central to Quantifying Masking Risk and Optimizing Adjunctive Imaging for Women with Dense Breasts
2. New Evidence Based Research in Treatment Techniques of Mobility in Older Adults- Healthclick Introduces New PT OT CME Course, Optimizing Functional Mobility in the Older
3. ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights
4. FDAnews Announces Human Factors and Usability Studies: Understanding and Optimizing Interaction with Medical Devices Webinar, July 16, 2015
5. Clinical Conductor CTMS Takes Aim at Optimizing Oncology Clinical Trials
6. Optimizing LGBT Health Under The Affordable Care Act: Strategies For Health Centers
7. TURBO - The Popular Bathroom Invention for Improved Health - Exceeds Kickstarter Goal with Nearly 500 Backers And 10 Days Left In Campaign
8. Multiple Myeloma Patients and Supporters Climb Mount Kilimanjaro, Raise Nearly $250,000 to Fund Cancer Research
9. Early Bird Pricing Deadline for Registration to Case Management Society of America's 26th Annual Conference & Expo Ending
10. Santa Rosa Orthopaedics (SRO) Shares Tips on Getting into Condition for an Early Spring
11. Chronic Care Management Company Releases Early CCM Program Results
Post Your Comments:
(Date:7/11/2019)... BETHESDA, Md. (PRWEB) , ... July 11, 2019 ... ... announced new knowledge tools and educational resources with a range of features ... their Members across the global pharmaceutical industry in manufacturing quality medicines for patients ...
(Date:7/10/2019)... ... ... HMP, a leader in healthcare events and education, today announced the Community Oncology ... October 11-13, 2019 in Boston. , Launched in 2016, the Congress is the official ... pathways as a decision support tool and their increasing influence on patient care. The ...
(Date:7/9/2019)... ... ... offer laser vaginal rejuvenation. Laser vaginal rejuvenation gives women a less painful and effective solution ... , vaginal dryness and burning , vaginal atrophy , ... imbalances , recurrent vaginal infections , vaginal and vulvar itching , ...
(Date:7/9/2019)... FREDERICK, Md. (PRWEB) , ... July 09, 2019 , ... ... cannabis testing, specifically for hemp plant material, oils, and solids. GEL Laboratories is based ... state. GEL Laboratories is also the first laboratory in the field of environmental ...
(Date:7/9/2019)... ... July 09, 2019 , ... Midmark ... today announced a validated integration between the Midmark real-time locating system (RTLS) and ... nurse call platform with location data since 1997 and is implemented in hundreds ...
Breaking Medicine News(10 mins):
(Date:7/9/2019)... ... 2019 , ... Chapters Health System, one of the nation’s ... Good Shepherd Hospice in Polk, Highlands and Hardee counties; HPH Hospice in Pasco, ... Care Connect and Palliative Care, today signed an initial agreement with Hospice of ...
(Date:7/9/2019)... ... July 09, 2019 , ... ... research and legislation, announces their schedule of events and theme for Fibroid Awareness ... reflects the inspired action of Fibroid Foundation Founder & CEO, Sateria Venable, that ...
(Date:7/9/2019)... ... July 09, 2019 , ... Building on its nationally recognized expertise ... natural CO2 Hemp Extract (CBD) . Unlike isolates or full spectrum oils, ... the benefits of the whole hemp plant, but with the tetrahydrocannabinol (THC) completely removed. ...
Breaking Medicine Technology: